Harnessing Artificial Intelligence to Overcome Key Challenges in Psychedelic Research and Therapy.
ACS Medicinal Chemistry Letters January 9, 2025 DOI: 10.1021/acsmedchemlett.4c00548 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy |
| Key findings | AI-driven models provide new insights into long-term efficacy, set and setting optimization, and alternative treatment methods, advancing psychedelic therapy into personalized medicine. |
Abstract
Artificial intelligence (AI) offers transformative potential in psychedelic research by addressing limitations in personalized treatment, predicting therapeutic outcomes, and understanding complex biological and environmental factors. AI-driven models provide new insights into long-term efficacy, set and setting optimization, and alternative treatment methods, advancing psychedelic therapy into personalized medicine.